Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
MODDERN Cures Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies
MODDERN Cures Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Issues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing programIssues related to pediatric medication access and impact of public guidelines on access Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number) Issues related to oncology legislation, including medication affordability Issues related to opiod use, diversion and DEA scheduling (no legislation) Issues related to transition of care from different care sites (no legislation) Issues related to drug safety and supply chain protections, including e-labeling (no bill number)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2015 · third_quarter · Q3
Medicare and Medicaid reform including issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
Patent litigation reform. Issues related to intellectual property practices in foreign countries and impact on US entities.
Source: Senate LDA
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3742 - Legislative proposals regarding the development and reimbursement of antibiotics Infant repiratory health issues - no legislation assigned
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity).
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Patent Abuse Reduction Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
Patent Litigation Integrity Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S 1720 - patent litigation reform; Issues related to intellectual property practices in foreign countries and impact on US entities
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S1720 - patent litigation reform. Issues Related to intellectual property practices in foreign countries and impact on US entities.
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
Patent Transparency and Improvements Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid program awareness, including discussions on potential changes to program strucutre Issues related to transition of care from different care sites (no legislation)
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform incluiding issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity).
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Stop Corporate Inversions Act of 2014
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid program awareness, including discussions on potential changes to program strucutre Issues related to transition of care from different care sites (no legislation)
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform incluiding issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Safeguarding America's Pharmaceuticals Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Safeguarding America's Pharmaceuticals Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Safeguarding America's Pharmaceuticals Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Safeguarding America's Pharmaceuticals Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program
End Anonymous Patents Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
To amend the Truth in Lending Act to allow certain loans that are not fully amortizing to be used in seller carryback financing on residential mortgage loans.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
PATENT Jobs Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2582 - Patent user fees H.R. 2766 - patent reform H.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
H.R. 2582 - Patent user fees H.R. 2766 - patent reform H.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies
Combination Drug Development Incentive Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
MODDERN Cures Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2582 - Patent user fees H.R. 2766 - patent reform H.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies
Drug Quality and Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Drug Quality and Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Drug Quality and Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Drug Quality and Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Drug Quality and Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 - issues related to the development of antibiotics S. 214, HR 845, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Issues related to data exclusivity for patented biological products (No assigned legislation)
Patent Abuse Reduction Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
FDA User Fee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
FDA User Fee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
FDA User Fee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
FDA User Fee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Mental Health First Aid Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs and non-interference Medicaid rebate formula (no assigned legislation)
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula and applicability Issues related to possible imposition of rebates for Medicare Part B drugs
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
REPEAL HIV Discrimination Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 - issues related to the development of antibiotics S. 214, HR 845, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Issues related to data exclusivity for patented biological products (No assigned legislation)
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
Excellence in Mental Health Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Medicare Drug Savings Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Patent Quality Improvement Act of 2013
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
Drug Supply Chain Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Drug Supply Chain Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program
Drug Supply Chain Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Drug Supply Chain Security Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Pharmaceutical Quality, Security, and Accountability Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program
Pharmaceutical Quality, Security, and Accountability Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Pharmaceutical Quality, Security, and Accountability Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
Pharmaceutical Quality, Security, and Accountability Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Generating Antibiotic Incentives Now Act of 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 - issues related to the development of antibiotics S. 214, HR 845, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Issues related to data exclusivity for patented biological products (No assigned legislation)
Generating Antibiotic Incentives Now Act of 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
Generating Antibiotic Incentives Now Act of 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
Generating Antibiotic Incentives Now Act of 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula and applicability Issues related to possible imposition of rebates for Medicare Part B drugs
Indonesian Family Refugee Protection Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Issues related to 21st Century Cures legislation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2015 · second_quarter · Q2
Issues related to 21st Century Cures legislation.
Patent litigation reform. Issues related to intellectual property practices in foreign countries and impact on US entities.
Medicare and Medicaid reform including issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2015 · first_quarter · Q1
Medicare and Medicaid reform including issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
Patent litigation reform. Issues related to intellectual property practices in foreign countries an dimpact on US entities.
Issues related to 21st Century Cures legislation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · second_quarter · 2A
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
S 1720 - patent litigation reform; Issues related to intellectual property practices in foreign countries and impact on US entities
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program; Issues related to pediatric medication access and impact of public guidelines on access; Issues related to oncology legislation,including medication affordability;Issues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures; Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number) (Jennifer Snow and Christine Bloomquist were deleted from this and the prior amendment to this report because they did not meet the legal definition of lobbyists)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · fourth_quarter · Q4
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform incluiding issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
HR 4679 Stop Corporate Inversions Act of 2014, S2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity).
S1720 - patent litigation reform. Issues Related to intellectual property practices in foreign countries and impact on US entities.
Antibiotic Development to Advance Patient Treatment Act. Issues related to oncology legislation, including medication affordability. Issues related to 21st Century Cures legislation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · third_quarter · Q3
HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies
Issues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures HR 3116 (MODDERN Cures Act) issues related to data exclusivity and patent rights for dormant therapies Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing programIssues related to pediatric medication access and impact of public guidelines on access Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number) Issues related to oncology legislation, including medication affordability Issues related to opiod use, diversion and DEA scheduling (no legislation) Issues related to transition of care from different care sites (no legislation) Issues related to drug safety and supply chain protections, including e-labeling (no bill number)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · second_quarter · 2A
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · second_quarter · 2A
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program Issues related to pediatric medication access and impact of public guidelines on access Issues related to oncology legislation, including medication affordabilityIssues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · second_quarter · Q2
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program Issues related to pediatric medication access and impact of public guidelines on access Issues related to oncology legislation, including medication affordabilityIssues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2014 · first_quarter · Q1
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3742 - Legislative proposals regarding the development and reimbursement of antibiotics Infant repiratory health issues - no legislation assigned
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · fourth_quarter · 4A
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · fourth_quarter · 4A
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · fourth_quarter · Q4
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · third_quarter · Q3
H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
H.R. 2582 - Patent user fees H.R. 2766 - patent reform H.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · second_quarter · Q2
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program
H.R.1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2013 · first_quarter · Q1
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 - issues related to the development of antibiotics S. 214, HR 845, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Issues related to data exclusivity for patented biological products (No assigned legislation)
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2012 · fourth_quarter · Q4
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety, supply chain, and facility inspections (No assigned legislation) Issues related to federal purchases under the Trade Agreements Act HR 6611 and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2012 · second_quarter · 2A
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada
H.R. 5651, S. 3187 (Prescription Drug User Fee Act (PFUFA)) FDA funding issues, including issues such as user fees and future appropriations HR 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) and related legislation related to issues of pediatric exclusivity S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2012 · second_quarter · Q2
H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2007 · mid_year · MM
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2006 · year_end · YY
H.R. 5337-National Security Foreign Investment Reform Act-re foreign investments in the US.
H.R. 3196-National Institute of Health Reauthorization-re tax breaks for research and development.
Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2004 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)
Issues related to drug safety and supply chain protections, including e-labeling (no bill number)
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid program awareness, including discussions on potential changes to program strucutre Issues related to transition of care from different care sites (no legislation)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program Issues related to pediatric medication access and impact of public guidelines on access Issues related to oncology legislation, including medication affordabilityIssues related to 21st Century Cures legislation and role of incentives in advancement of treatments and cures Issues related to FDA and Biomedical Advanced Research Development Authority appropriations (no bill number) Medication adherence related legislation (no bill number)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
S 1720 - patent litigation reform Issues related to intellectual property practices in foreign countries and impact on US entities
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 1919, H.R. 3204, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections Legislative proposals regarding the development of antibiotics (no assigned legislation) H.R. 2725, S. 1413 - FDA user feesH.R. 3116 - MODDERN Cures Act - legislation to provide patent incentives for the development of innovative diagnostic tests therapies Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 2985 - regarding the development of new combination drugs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs and non-interference Medicaid rebate formula (no assigned legislation)
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula and applicability Issues related to possible imposition of rebates for Medicare Part B drugs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation
H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates
Issues related to implementation of US-Korea Free Trade Agreement Issues related to Non-tariff trade barriers in Turkey Issues related to US position on intellectual property matters in Canada
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
H.R. 5651, S. 3187 (Prescription Drug User Fee Act (PFUFA)) FDA funding issues, including issues such as user fees and future appropriations HR 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) and related legislation related to issues of pediatric exclusivity S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes
Issues related to implementation of US-Korea Free Trade Agreement Issues related to Non-tariff trade barriers in Turkey Issues related to US position on intellectual property matters in Canada
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D outreach efforts & participation in CMS Partnership Strategy Group. Medicaid Reform & Medicare/Patient Assistance Programs integration issues.
H.R. 5122-Defense Authorization Bill-re price control issues. S.2766-Defense Authorization Bill- re price control issues. Prescription Drug User Fee Act issues. S.3695, Food, Drug, & Cosmetic Act amendments, provisions regarding authorized generic drugs and the 180 day exclusivity period; S.2300,Lower Priced Drug Act, provisions relating to 180 day exclusivity regarding period pediatric studies.
H.R.2795-Patent Reform Act of 2005-re reforms to the patent system. S.3818-Patent Reform Act of 2006-re reforms to the patent system.
H.R.6275-Minority Outreach-re health disparities bill.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE